New drug pricing policy linked with price and volume.

Published: 2004-09-01 06:59:00

Updated: 2004-09-01 06:59:00

The future drug pricing policy may link with its price and prescribing volume and the already registered drugs will be reclassified in consideration with its therapeutic efficacies.

Based on their study outcomes for the NHI development policy the NHI Development Council (Chief: Yang Bong-min),...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK